NEW YORK (

TheStreet

) --

CHANGE IN RATINGS

Abercrombie & Fitch

(ANF) - Get Report

was downgraded to hold at TheStreet Ratings.

Cubist

(CBST)

was upgraded at Mizuho to buy from neutral. $77 price target. Acquisitions should help drive near-term growth, Mizuho said.

C&J Energy

(CJES)

was downgraded at Cowen to market perform from outperform. $22.30 price target. Fracturing services market continues to suffer from chronic oversupply, Cowen said.

Ellington Financial

(EFC) - Get Report

was upgraded to hold at TheStreet Ratings.

Read: Ariad Pharma Plunges on Disclosure of Iclusig Toxicity

EOG Resources

(EOG) - Get Report

was upgraded at Credit Suisse to outperform from neutral. $175 price target. Estimates were also increased, given higher oil production forecasts, Credit Suisse said.

Iberiabank

(IBKC) - Get Report

was downgraded at Oppenheimer to perform from outperform. Company is seeing pressure in mortgage banking, Oppenheimer said.

K12

(LRN) - Get Report

was downgraded at Robert Baird to neutral from outperform. $25 price target. Company slashed its guidance, Baird said.

K12 was downgraded at BMO Capital to market perform from outperform. $22 price target. Company is seeing lower enrollment growth, BMO Capital said.

Masco

(MAS) - Get Report

was upgraded at J.P. Morgan to overweight from neutral. $21 price target. Valuation is reasonable against unaggressive 2015 estimates, J.P. Morgan said.

Read: The Ups and Downs Among Internet Stocks

TheStreet Recommends

Merck

(MRK) - Get Report

was initiated with a neutral rating at Credit Suisse. $49 price target. Core franchises are facing growth challenges, Credit Suisse said.

Owens Corning

(OC) - Get Report

was upgraded at J.P. Morgan to overweight from neutral. $45 price target. More constructive view on repair/remodel focused building product names, J.P. Morgan said.

Pfizer

(PFE) - Get Report

was initiated with an outperform rating at Credit Suisse. $34 price target. Restructuring story will likely continue to evolve, Credit Suisse said.

Patterson-UTI

(PTEN) - Get Report

was downgraded at Cowen to perform from outperform. $24 price target. Pressure pumping prices will likely show no improvement, Cowen said.

Viropharma

(VPHM)

was downgraded at Mizuho to neutral from buy. Valuation call, based on a $39 price target, Mizuho said.

Read: What to Do When You Get Yelled at in the Office

Stock Comments / EPS Changes

Hain Celestial

(HAIN) - Get Report

estimates were cut at Jefferies through 2013. Guidance below consensus at analyst day, Jefferies said. Buy rating and $91 price target.

Precision Castparts

(PCP)

estimates were cut at Jefferies through 2013. Delayed closing of Permaswage, Jefferies said. Hold rating and $235 price target.

>To submit a news tip, email:

tips@thestreet.com

.

Follow

TheStreet

on

Twitter

and become a fan on

Facebook.

This article was written by a staff member of TheStreet.